WHAT'S NEW IN CANCER?

There are many exciting advances in the diagnosis and treatment of different types of cancer. People are surviving longer and some previously deadly cancers are even being cured. Here's a sampling of some recent innovations:

CAR T-cell therapy has been remarkably effective for certain blood cancers. with some people having complete remissions lasting 18-24 months and more. Stanford oncologist Josh Mansour M.D. explains the current and future prospects of this innovative treatment approach. READ MORE:

Digital diagnostics company Cernostics is applying a tissue systems approach to an important clinical problem - determining which people with Barrett's esophagus (a precursor to esophageal cancer) will actually progress to that often deadly disease. Instead of just looking at the anatomic pathology of a biopsy, they analyze it at molecular, cellular and proteomic levels. READ MORE:

A giant in the field of pharmaceuticals, including cancer therapeutics, Harvey Berger M.D. wrote a 3-Part series for us on Difficult to Treat Cancers. In Part 3, he describes the clinical trial outcomes being achieved by a number of new drugs that are being used to treat various cancers. The progress has been astonishing. READ MORE:

More from The Doctor Weighs In and Around the Web

Breast implants have been associated with a rare but serious form of cancer called Breast Implant-Associated Anaplastic Large Cell Lymphoma. Apparently, a specific type of implant called textured breast implants is the culprit.

Liquid biopsy for cancer has the potential to advance many aspects of cancer care (diagnosis, determining the effectiveness of treatment, monitoring relapse and more). Imagine one day doing all of those things with a blood test instead of imaging or biopsy.

Here's a summary of clinical advances in cancer for 2019 from the recent American Society of Clinical Oncology (ASCO) meetings. The latest and greatest!

A small study demonstrates that a new laser tech can detect circulating cancer cells in melanoma patients at levels far more sensitive than currently available technologies.

You can see all of our stories on cancer by clicking HERE.

Please subscribe to our newsletter (click on the subscribe button) and let us know what you like and what you don't in this first one. And, please offer suggestions for future newsletters.